Mohan Bala

Insider Reports History

Entity
Individual
Location
C/O Mersana Therapeutics, Inc., 840 Memorial Drive, Cambridge, MA
Signature
/s/ Alejandra Carvajal, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mohan Bala:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mersana Therapeutics, Inc. SVP, Chief Development Officer Restricted Stock Unit 58.3K $158K $2.71 Jan 15, 2024 Direct
Mersana Therapeutics, Inc. SVP, Chief Development Officer Common Stock 54.7K $104K $1.90 Oct 28, 2024 Direct
Mersana Therapeutics, Inc. SVP, Chief Development Officer Restricted Stock Unit 6.25K $12.3K $1.96 Oct 25, 2024 Direct
Mersana Therapeutics, Inc. SVP, Chief Development Officer Stock Option (Right to Buy) 263K Jan 15, 2024 Direct

Insider Reports Filed by Mohan Bala

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRSN Mersana Therapeutics, Inc. Oct 25, 2024 3 -$3.58K 4 Oct 29, 2024 SVP, Chief Development Officer
MRSN Mersana Therapeutics, Inc. Oct 1, 2024 4 -$27.2K 4 Oct 7, 2024 SVP, Chief Development Officer
MRSN Mersana Therapeutics, Inc. Jan 13, 2024 5 -$9.3K 4 Jan 17, 2024 SVP, Chief Development Officer
MRSN Mersana Therapeutics, Inc. Oct 25, 2023 3 -$2.16K 4 Oct 27, 2023 SVP, Chief Development Officer
MRSN Mersana Therapeutics, Inc. Sep 5, 2023 0 $0 3 Sep 7, 2023 SVP, Chief Development Officer